Yang Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yang Bai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Bo Fu
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy Harbin Medical University Harbin China
1 shared publication - Cong Li
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy Harbin Medical University Harbin China
1 shared publication - Danfeng Zhao
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy Harbin Medical University Harbin China
1 shared publication - Fanshu Zeng
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy Harbin Medical University Harbin China
1 shared publication - Feng Xiong
Department of Urology (Heilongjiang Key Laboratory of Scientific Research in Urology) The Fourth Hospital of Harbin Medical University Harbin China
1 shared publication - Guang Yang
Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, China
1 shared publication
Latest Publications
- Open Access
- 2 August 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (9) , e23118
LncRNA PVT1 promotes strong stemness and endothelial progenitor cell characteristics in renal carcinoma stem cells
Renal cancer stem cells (RCSCs) derived from clear cell renal cell carcinoma (ccRCC) tissues with higher microvessel density (MVD) have strong stemness and endothelial progenitor cells‐like (EPCs‐like) characteristics. A high level of lncRNA PVT1 expression is essential for simultaneously retaining strong RCSC stemness and EPCs‐like characteristics. PVT1 binds with TAZ protein and prevents its phosphorylation, which promotes RCSC stemness. Moreover, RCSCs support endothelial differentiation and angiogenesis, which are mediated via the PVT1/miR‐15b/KDR axis. This report provides insight into the determinants of RCSC impact on stemness and highlights the critical role of RCSC in angiogenesis. The presented findings suggest that targeting RCSC through PVT1 expression may be a new treatment strategy for ccRCC.
- 2 August 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (9) , e23118
Open AccessLncRNA PVT1 promotes strong stemness and endothelial progenitor cell characteristics in renal carcinoma stem cells
Renal cancer stem cells (RCSCs) derived from clear cell renal cell carcinoma (ccRCC) tissues with higher microvessel density (MVD) have strong stemness and endothelial progenitor cells‐like (EPCs‐like) characteristics. A high level of lncRNA PVT1 expression is essential for simultaneously retaining strong RCSC stemness and EPCs‐like characteristics. PVT1 binds with TAZ protein and prevents its phosphorylation, which promotes RCSC stemness. Moreover, RCSCs support endothelial differentiation and angiogenesis, which are mediated via the PVT1/miR‐15b/KDR axis. This report provides insight into the determinants of RCSC impact on stemness and highlights the critical role of RCSC in angiogenesis. The presented findings suggest that targeting RCSC through PVT1 expression may be a new treatment strategy for ccRCC.